Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf is a New York Plaintiff's personal injury law firm specializing in automobile accidents, construction accidents, medical malpractice, products liability, police misconduct and all types of New York personal injury litigation.

Articles Posted in Failure to Diagnose Cancer

Published on:

There is a higher rate of failure to diagnose breast cancer among women who are screened using computed radiography compared to women who are screened using digital direct radiography according to a new study lead by Anna M. Chiarelli, Ph.D., senior scientist in Prevention and Cancer Control at Cancer Care Ontario in Toronto, and published online in the journal Radiology.

The study results show that cancer detection with digital mammography that involves direct radiography technology was similar to that with screen film mammography in women aged 50–74 years; however, for computed radiography the risk of cancer detection is significantly lower-by 21%-among all screening techniques.

Published on:

Regular mammograms allow early diagnosis of breast cancer and can save lives. For it’s annual May breast cancer awareness campaign, HCC invites New York City’s public Hospital Staff to “dedicate” their Mammogram to someone they love to promote mammograms awareness.

New%20York%20mammogram-infographic.jpg

Published on:

Colon cancer is the third most commonly diagnosed cancer and the third leading cause of cancer death in the US. Although it is largely preventable through colonoscopy, screening remains underutilized.

A recent study by Hanna M. Zafar, MD, MHS at the Perelman School of Medicine at the University of Pennsylvania shows that despite reimbursement limitations, computed tomography colonography (CTC) or virtual colonoscopy may expand screening to more patients. The study “Predictors of CT Colonography Utilization Among Asymptomatic Medicare Beneficiaries” can be found online in the Journal of General Internal Medicine.

Published on:

In “Beyond Mammography: New Frontiers in Breast Cancer Screening”, American Journal of Medicine, Jennifer S. Drukteinis, MD (Moffitt Cancer Center), Blaise P. Mooney, MD, Chris I. Flowers, MBBS, Robert A. Gatenby, MD, look at a personalized approach to breast cancer screening using new technologies such as low-dose mammography, contrast-enhanced mammography, tomosynthesis, automated whole breast ultrasound, molecular imaging, and magnetic resonance imaging. The study says this approach may lead to a better detection of breast cancer both in the general population and in high-risk groups, such as women with dense breasts.